Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)

BACKGROUND: People living with HIV (PLWH) have been reported to have a higher risk of more severe COVID-19 disease and death. We assessed the ability of the Ad26.CoV2.S vaccine to elicit neutralizing activity against the Delta variant in PLWH relative to HIV-negative individuals. We also examined ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Khadija, Lustig, Gila, Bernstein, Mallory, Archary, Derseree, Cele, Sandile, Karim, Farina, Smith, Muneerah, Ganga, Yashica, Jule, Zesuliwe, Reedoy, Kajal, Miya, Yoliswa, Mthabela, Ntombifuthi, Magula, Nombulelo P, Lessells, Richard, de Oliveira, Tulio, Gosnell, Bernadett I, Abdool Karim, Salim, Garrett, Nigel, Hanekom, Willem, Bekker, Linda-Gail, Gray, Glenda, Blackburn, Jonathan M, Moosa, Mahomed-Yunus S, Sigal, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689810/
https://www.ncbi.nlm.nih.gov/pubmed/34893824
http://dx.doi.org/10.1093/cid/ciab1008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689810/
https://www.ncbi.nlm.nih.gov/pubmed/34893824
http://dx.doi.org/10.1093/cid/ciab1008

Ejemplares similares